Welcome to our dedicated page for Ryan Specialty Hldgs SEC filings (Ticker: RYAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ryan Specialty Holdings, Inc. filings document the public-company records of a specialty insurance intermediary with Class A common stock listed on the New York Stock Exchange. Its 8-K reports cover operating and financial results, regular quarterly dividends, share repurchase activity, material agreements involving equity compensation and stock repurchases, and Regulation FD disclosures related to company announcements.
Ryan Specialty proxy and governance filings describe director elections, annual meeting voting results, independent auditor ratification, advisory executive compensation votes, board composition, shareholder proposal procedures, named executive compensation, equity awards and related governance matters. The filings also record director transitions and capital-structure disclosures tied to the company’s incentive plans and shareholder return programs.
Ryan Specialty Holdings reported solid growth for the quarter ended March 31, 2026. Total revenue rose to $795.2 million, driven mainly by net commissions and fees of $782.9 million, up from $676.1 million a year earlier. Net income was $40.6 million, compared with a net loss of $4.4 million in the prior-year quarter, and diluted earnings per Class A share improved to $0.13 from a loss of $0.22.
The company remains highly leveraged, with total debt of about $3.57 billion and significant use of its $1.4 billion revolving credit facility. It launched the Empower restructuring program, expecting total costs of $160 million through 2028 and projected annual savings of about $80 million in 2029. During the quarter, Ryan Specialty repurchased 982,073 Class A shares for roughly $40 million and paid a regular quarterly cash dividend of $0.13 per Class A share.
RYAN PATRICK G JR reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings, Inc. director Ryan Patrick G Jr reported an equity award of 5,757 shares of Class A Common Stock, delivered as Restricted Stock Units that vested immediately upon grant. The grant carried a per-share price of $0.00, reflecting compensation rather than a market purchase.
Following the award, he directly owns 262,316.053 Class A shares. In addition, 428,295 Class A shares are held in trusts for his and/or family members’ benefit, where he serves as trustee and disclaims beneficial ownership except for his pecuniary interest. The grant was approved by the Board for purposes of Rule 16(b)(3).
ROGERS JOHN W JR reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings director John W. Rogers Jr. received an award of 5,757 shares of Class A Common Stock in the form of Restricted Stock Units that vested immediately upon grant. He elected to defer settlement of these units until his separation from the board of directors, consistent with the company’s director compensation program.
Following this award, he directly holds or has deferred rights tied to a total of 110,433 shares, which includes 15,270 previously granted Restricted Stock Units that also vested immediately upon grant and are similarly deferred until he leaves board service.
OHALLERAN MICHAEL D reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings director Michael D. O’Halleran received a grant of 5,757 Restricted Stock Units (RSUs) that vested immediately upon grant on Class A Common Stock. He elected to defer settlement of these RSUs until his separation from service on the board of directors.
After this award, he holds 238,963 shares directly and 581,952 shares indirectly through the Trust of Michael D. O'Halleran dated January 17, 1997. The indirect holdings include 20,580 RSUs that also vested immediately upon grant and are similarly deferred. The grant was approved by the board for purposes of Rule 16(b)(3).
Kuczinski Anthony J reported acquisition or exercise transactions in this Form 4 filing.
RYAN SPECIALTY HOLDINGS, INC. director Anthony J. Kuczinski reported receiving 5,757 shares of Class A Common Stock as a grant, recorded at a price of $0.00 per share. These represent Restricted Stock Units that vested immediately, but he elected to defer settlement until he leaves the board.
After this award, his directly reported holdings increased to 10,072 shares. The footnotes add that his position also reflects 8,080 Restricted Stock Units that vested immediately on grant, for which settlement has likewise been deferred until his separation from board service. This filing reflects routine, compensation-related equity awards rather than open‑market buying or selling.
RYAN SPECIALTY HOLDINGS, INC. director Nicholas Dominic Cortezi received an award of 5,757 shares of Class A Common Stock on April 28, 2026, reported as an acquisition under a grant or award.
The footnotes explain these reported securities are Restricted Stock Units that vested immediately, with settlement deferred until his separation from service on the board. After this award, he is shown as directly owning 10,777 shares. The grant was approved by the issuer’s board of directors for purposes of Rule 16(b)(3), indicating it is a standard, board-approved compensation grant rather than an open-market transaction.
Cornelli Francesca reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings director Francesca Cornelli received an equity award in the form of Restricted Stock Units (RSUs). On the grant date, 5,757 RSUs vested immediately, but settlement into Class A Common Stock will occur only after her separation from the board, reflecting deferred compensation rather than a cash purchase.
Following this award, Cornelli is reported with 10,377 Class A Common Stock shares associated with her position. The grant was approved by the company’s board of directors for purposes of Rule 16(b)(3), indicating it is a board-sanctioned, routine director compensation grant rather than an open-market transaction.
COLLINS MICHELLE L reported acquisition or exercise transactions in this Form 4 filing.
Director Michelle L. Collins of Ryan Specialty Holdings, Inc. received a grant of 5,757 shares of Class A Common Stock in the form of Restricted Stock Units. The award was issued at a reported price of $0.00 per share, reflecting compensation rather than a market purchase.
These RSUs vested immediately upon grant, but Collins elected to defer settlement until her separation from the board of directors. After this grant, she holds a total of 19,219 shares of Class A Common Stock in direct ownership, including 16,219 RSUs that have vested immediately upon grant and are subject to similar deferred settlement.
BUNGERT MICHAEL G reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings director granted equity award
Director Michael G. Bungert received an award of 4,615 Restricted Stock Units tied to Ryan Specialty Holdings Class A common stock. The units vested immediately upon grant, but he elected to defer settlement until his separation from service on the board of directors.
The grant had a stated price of $0.00 per share, reflecting that it is a compensation award rather than a market purchase. Following this award, his reported direct position from this grant is 4,615 units.
BOLGER DAVID P reported acquisition or exercise transactions in this Form 4 filing.
RYAN SPECIALTY HOLDINGS, INC. director David P. Bolger received an equity award of 5,757 shares of Class A Common Stock in the form of Restricted Stock Units that vested immediately upon grant at $0.00 per share. According to the filing, settlement of these units is deferred until his separation from service on the board, and the grant was approved by the board for purposes of Rule 16(b)(3). Following the award, he holds 20,580 Class A shares directly and 66,467 Class A shares indirectly through the David P. Bolger Revocable Trust dated 10/30/1995, with beneficial ownership disclaimed except to the extent of his pecuniary interest.